Filtered By:
Specialty: Biomedical Science
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 5325 results found since Jan 2013.
Within-Host Evolution of SARS-CoV-2 in a B-Cell Depleted Patient With Successful Treatment
J Korean Med Sci. 2023 Jun 5;38(22):e175. doi: 10.3346/jkms.2023.38.e175.ABSTRACTProlonged viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised host is a challenge as the treatment and infection control for chronic coronavirus disease 2019 infection is not well established and there is a potential risk of new variants emerging. A 48-year-old woman who underwent chemotherapy, including rituximab and steroid, had reactivation of SARS-CoV-2 68 days after the virus was first detected. She successfully recovered after receiving convalescent plasma and intravenous immunoglobulin....
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Yae Jee Baek Gemma Park Jun Yong Choi Eun Jin Kim Bryan Inho Kim Jin Gwack Ji Ye Jung Source Type: research
A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors
CONCLUSION: Approximately 90% of participants reported AEs following mRNA COVID-19 vaccination. Substantial factors, including vaccine type (mRNA-1273), female sex, and dermatologic diseases were associated with AEs. Our findings could aid policymakers in establishing vaccination strategies tailored to those potentially susceptible to AEs.PMID:37272559 | PMC:PMC10244024 | DOI:10.3346/jkms.2023.38.e170
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Dongwon Yoon Ha-Lim Jeon Yunha Noh Young June Choe Seung-Ah Choe Jaehun Jung Ju-Young Shin Source Type: research
Within-Host Evolution of SARS-CoV-2 in a B-Cell Depleted Patient With Successful Treatment
J Korean Med Sci. 2023 Jun 5;38(22):e175. doi: 10.3346/jkms.2023.38.e175.ABSTRACTProlonged viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised host is a challenge as the treatment and infection control for chronic coronavirus disease 2019 infection is not well established and there is a potential risk of new variants emerging. A 48-year-old woman who underwent chemotherapy, including rituximab and steroid, had reactivation of SARS-CoV-2 68 days after the virus was first detected. She successfully recovered after receiving convalescent plasma and intravenous immunoglobulin....
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Yae Jee Baek Gemma Park Jun Yong Choi Eun Jin Kim Bryan Inho Kim Jin Gwack Ji Ye Jung Source Type: research
A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors
CONCLUSION: Approximately 90% of participants reported AEs following mRNA COVID-19 vaccination. Substantial factors, including vaccine type (mRNA-1273), female sex, and dermatologic diseases were associated with AEs. Our findings could aid policymakers in establishing vaccination strategies tailored to those potentially susceptible to AEs.PMID:37272559 | PMC:PMC10244024 | DOI:10.3346/jkms.2023.38.e170
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Dongwon Yoon Ha-Lim Jeon Yunha Noh Young June Choe Seung-Ah Choe Jaehun Jung Ju-Young Shin Source Type: research
Within-Host Evolution of SARS-CoV-2 in a B-Cell Depleted Patient With Successful Treatment
J Korean Med Sci. 2023 Jun 5;38(22):e175. doi: 10.3346/jkms.2023.38.e175.ABSTRACTProlonged viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised host is a challenge as the treatment and infection control for chronic coronavirus disease 2019 infection is not well established and there is a potential risk of new variants emerging. A 48-year-old woman who underwent chemotherapy, including rituximab and steroid, had reactivation of SARS-CoV-2 68 days after the virus was first detected. She successfully recovered after receiving convalescent plasma and intravenous immunoglobulin....
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Yae Jee Baek Gemma Park Jun Yong Choi Eun Jin Kim Bryan Inho Kim Jin Gwack Ji Ye Jung Source Type: research
A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors
CONCLUSION: Approximately 90% of participants reported AEs following mRNA COVID-19 vaccination. Substantial factors, including vaccine type (mRNA-1273), female sex, and dermatologic diseases were associated with AEs. Our findings could aid policymakers in establishing vaccination strategies tailored to those potentially susceptible to AEs.PMID:37272559 | PMC:PMC10244024 | DOI:10.3346/jkms.2023.38.e170
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Dongwon Yoon Ha-Lim Jeon Yunha Noh Young June Choe Seung-Ah Choe Jaehun Jung Ju-Young Shin Source Type: research
Within-Host Evolution of SARS-CoV-2 in a B-Cell Depleted Patient With Successful Treatment
J Korean Med Sci. 2023 Jun 5;38(22):e175. doi: 10.3346/jkms.2023.38.e175.ABSTRACTProlonged viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised host is a challenge as the treatment and infection control for chronic coronavirus disease 2019 infection is not well established and there is a potential risk of new variants emerging. A 48-year-old woman who underwent chemotherapy, including rituximab and steroid, had reactivation of SARS-CoV-2 68 days after the virus was first detected. She successfully recovered after receiving convalescent plasma and intravenous immunoglobulin....
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Yae Jee Baek Gemma Park Jun Yong Choi Eun Jin Kim Bryan Inho Kim Jin Gwack Ji Ye Jung Source Type: research
A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors
CONCLUSION: Approximately 90% of participants reported AEs following mRNA COVID-19 vaccination. Substantial factors, including vaccine type (mRNA-1273), female sex, and dermatologic diseases were associated with AEs. Our findings could aid policymakers in establishing vaccination strategies tailored to those potentially susceptible to AEs.PMID:37272559 | PMC:PMC10244024 | DOI:10.3346/jkms.2023.38.e170
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Dongwon Yoon Ha-Lim Jeon Yunha Noh Young June Choe Seung-Ah Choe Jaehun Jung Ju-Young Shin Source Type: research
Within-Host Evolution of SARS-CoV-2 in a B-Cell Depleted Patient With Successful Treatment
J Korean Med Sci. 2023 Jun 5;38(22):e175. doi: 10.3346/jkms.2023.38.e175.ABSTRACTProlonged viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised host is a challenge as the treatment and infection control for chronic coronavirus disease 2019 infection is not well established and there is a potential risk of new variants emerging. A 48-year-old woman who underwent chemotherapy, including rituximab and steroid, had reactivation of SARS-CoV-2 68 days after the virus was first detected. She successfully recovered after receiving convalescent plasma and intravenous immunoglobulin....
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Yae Jee Baek Gemma Park Jun Yong Choi Eun Jin Kim Bryan Inho Kim Jin Gwack Ji Ye Jung Source Type: research
A Nationwide Survey of mRNA COVID-19 Vaccinee's Experiences on Adverse Events and Its Associated Factors
CONCLUSION: Approximately 90% of participants reported AEs following mRNA COVID-19 vaccination. Substantial factors, including vaccine type (mRNA-1273), female sex, and dermatologic diseases were associated with AEs. Our findings could aid policymakers in establishing vaccination strategies tailored to those potentially susceptible to AEs.PMID:37272559 | DOI:10.3346/jkms.2023.38.e170
Source: Journal of Korean Medical Science - June 5, 2023 Category: Biomedical Science Authors: Dongwon Yoon Ha-Lim Jeon Yunha Noh Young June Choe Seung-Ah Choe Jaehun Jung Ju-Young Shin Source Type: research
Optimal allocation of scarce PCR tests during the COVID-19 pandemic
ConclusionA mathematical model that allows for the optimal allocation of scarce PCR tests during the COVID-19 pandemic was developed.
Source: PLoS One - June 5, 2023 Category: Biomedical Science Authors: Afschin Gandjour Source Type: research
Clinical characteristics and outcomes of hospitalized patients with COVID-19 in a city of South Brazil: Have they changed through the first year of the pandemic?
This study aimed to describe changes in the clinical characteristics and outcomes of hospitalized patients during the first year of the COVID-19 pandemic in a city in southern Brazil. This prospective study was carried out in two tertiary care private hospitals in Curitiba. A total of 1151 patients hospitalized between March 2020 and March 2021 were included. We identified three epidemiological critical periods of the pandemic and compared patients’ characteristics and the frequencies of oral intubation, intensive care unit (ICU) admission and mortality. Continuous variables were analyzed by variance analysis model (ANOV...
Source: PLoS One - June 1, 2023 Category: Biomedical Science Authors: Henrique Demeneck Source Type: research
Physical distancing and emergency medical services utilization after self-harm in Korea during the early COVID-19 pandemic: A nationwide quantitative study
ConclusionPhysical distancing measures adopted to prevent the spread of transmittable diseases following the pandemic had the effect of decreasing ED visits due to self-harm. When the pandemic has ended, and daily life has been restored, it will be particularly important to pay attention to the increased numbers of self-harm patients expected to visit EDs compared to during the pandemic.
Source: PLoS One - May 30, 2023 Category: Biomedical Science Authors: Ye Ji Lee Source Type: research
Assessing the potential of polygenic scores to strengthen medical risk prediction models of COVID-19
by Aldo C órdova-Palomera, Csaba Siffel, Chris DeBoever, Emily Wong, Dorothée Diogo, Sandor Szalma
As findings on the epidemiological and genetic risk factors for coronavirus disease-19 (COVID-19) continue to accrue, their joint power and significance for prospective clinical applications remains virtually unexplored. Severity of symptoms in individuals affected by COVID-19 spans a broad spectr um, reflective of heterogeneous host susceptibilities across the population. Here, we assessed the utility of epidemiological risk factors to predict disease severity prospectively, and interrogated genetic information (polygenic...
Source: PLoS One - May 26, 2023 Category: Biomedical Science Authors: Aldo C órdova-Palomera Source Type: research
Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
CONCLUSION: The cellular and humoral immune responses were low in the CCB group so that the breakthrough infection occurred faster in the CCB group than in the BBB group.PMID:37218354 | DOI:10.3346/jkms.2023.38.e155
Source: Journal of Korean Medical Science - May 23, 2023 Category: Biomedical Science Authors: Seong-Ho Choi Ji Young Park Oh Joo Kweon Joung Ha Park Min-Chul Kim Yaeji Lim Jin-Won Chung Source Type: research
